Should we be concerned about gastrointestinal‐related adverse events in patients with plaque psoriasis receiving secukinumab therapy? A retrospective, real‐life study

Real‐world secukinumab gastrointestinal‐related adverse events (GIRAE) data in psoriatic patients treated with secukinumab are lacking. A descriptive, retrospective study was performed by reviewing the medical records of patients who received secukinumab for plaque psoriasis for at least 1 year and...

Descripción completa

Detalles Bibliográficos
Autores principales: Diotallevi, Federico, Gambini, Daisy, Radi, Giulia, Simonetti, Oriana, Offidani, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786729/
https://www.ncbi.nlm.nih.gov/pubmed/36038514
http://dx.doi.org/10.1111/dth.15794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786729/
https://www.ncbi.nlm.nih.gov/pubmed/36038514
http://dx.doi.org/10.1111/dth.15794

Ejemplares similares